DE3044072A1 - Bis-aminomehtyl-anthrachinon-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung - Google Patents

Bis-aminomehtyl-anthrachinon-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung

Info

Publication number
DE3044072A1
DE3044072A1 DE19803044072 DE3044072A DE3044072A1 DE 3044072 A1 DE3044072 A1 DE 3044072A1 DE 19803044072 DE19803044072 DE 19803044072 DE 3044072 A DE3044072 A DE 3044072A DE 3044072 A1 DE3044072 A1 DE 3044072A1
Authority
DE
Germany
Prior art keywords
anthraquinone
bis
formula
aminomethyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19803044072
Other languages
German (de)
English (en)
Inventor
Wolfgang Dr. 6072 Dreieichenhain Raether
Heinrich Dr. 6233 Kelkheim Rolly
Erhardt Dr. 6233 Kelkheim Winkelmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Priority to DE19803044072 priority Critical patent/DE3044072A1/de
Priority to EP81109738A priority patent/EP0052853A1/de
Priority to ES507234A priority patent/ES8303385A1/es
Priority to GR66570A priority patent/GR78224B/el
Priority to FI813709A priority patent/FI813709L/fi
Priority to JP56185574A priority patent/JPS57118540A/ja
Priority to IL64336A priority patent/IL64336A0/xx
Priority to NO813974A priority patent/NO813974L/no
Priority to DK519581A priority patent/DK519581A/da
Priority to AR287543A priority patent/AR227341A1/es
Priority to KR1019810004526A priority patent/KR830007489A/ko
Priority to AU77766/81A priority patent/AU7776681A/en
Priority to PT74023A priority patent/PT74023B/pt
Priority to ZA818107A priority patent/ZA818107B/xx
Publication of DE3044072A1 publication Critical patent/DE3044072A1/de
Priority to ES516225A priority patent/ES8306734A1/es
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00—Preparation of quinones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/24—Quinones containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/34—Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having three rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C07D295/116—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings with the doubly bound oxygen or sulfur atoms directly attached to a carbocyclic ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19803044072 1980-11-24 1980-11-24 Bis-aminomehtyl-anthrachinon-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung Withdrawn DE3044072A1 (de)

Priority Applications (15)

Application Number Priority Date Filing Date Title
DE19803044072 DE3044072A1 (de) 1980-11-24 1980-11-24 Bis-aminomehtyl-anthrachinon-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
EP81109738A EP0052853A1 (de) 1980-11-24 1981-11-17 Bis-Aminomethyl-anthrachinon-Derivate, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung
ES507234A ES8303385A1 (es) 1980-11-24 1981-11-18 Procedimiento para la preparacion de derivados de bis-amino-metil-antraquinona.
GR66570A GR78224B (ko) 1980-11-24 1981-11-19
FI813709A FI813709L (fi) 1980-11-24 1981-11-20 Bis-aminometylantrakinonderivat foerfaranden foer deras framstaellning dessa innehaollande laekemedel och deras anvaendning
JP56185574A JPS57118540A (en) 1980-11-24 1981-11-20 Bis-aminomethyl-anthraquinone derivative
IL64336A IL64336A0 (en) 1980-11-24 1981-11-22 Bis-aminomethyl-anthraquinone derivatives,a process for their preparation,agents containing them and their use
NO813974A NO813974L (no) 1980-11-24 1981-11-23 Bis-aminometyl-antrakinon-derivater, fremgangsmaate til deres fremstilling, midler inneholdende disse og deres anvendelse
DK519581A DK519581A (da) 1980-11-24 1981-11-23 Bis-aminomethyl-antraquinon-derivater deres fremstilling og anvendelse
AR287543A AR227341A1 (es) 1980-11-24 1981-11-23 Procedimiento para preparar derivados de bis-aminometil-antraquinona
KR1019810004526A KR830007489A (ko) 1980-11-24 1981-11-23 비스-아미노메틸- 안트라퀴논 유도체의 제조방법
AU77766/81A AU7776681A (en) 1980-11-24 1981-11-23 Bisaminomethyl-anthraquinone derivatives
PT74023A PT74023B (de) 1980-11-24 1981-11-23 Bis-aminomethyl-anthrachinon-derivate verfahren zu ihrer herstellung sie enthaltende mittel und ihre verwendung
ZA818107A ZA818107B (en) 1980-11-24 1981-11-23 Bis-aminomethyl-anthraquinone derivatives,a process for their preparation,agents containing them and their use
ES516225A ES8306734A1 (es) 1980-11-24 1982-10-05 "procedimiento para la preparacion de derivados de bis-aminometil-antraquinona".

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803044072 DE3044072A1 (de) 1980-11-24 1980-11-24 Bis-aminomehtyl-anthrachinon-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung

Publications (1)

Publication Number Publication Date
DE3044072A1 true DE3044072A1 (de) 1982-07-15

Family

ID=6117355

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803044072 Withdrawn DE3044072A1 (de) 1980-11-24 1980-11-24 Bis-aminomehtyl-anthrachinon-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung

Country Status (4)

Country Link
JP (1) JPS57118540A (ko)
KR (1) KR830007489A (ko)
DE (1) DE3044072A1 (ko)
ZA (1) ZA818107B (ko)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101730531A (zh) * 2007-05-10 2010-06-09 阿瓦隆药品公司 芴、蒽、呫吨、二苯并环庚酮和吖啶的衍生物及其用途
WO2016116527A1 (de) * 2015-01-20 2016-07-28 Cynora Gmbh Organische moleküle, insbesondere zur verwendung in optoelektronischen bauelementen

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101730531A (zh) * 2007-05-10 2010-06-09 阿瓦隆药品公司 芴、蒽、呫吨、二苯并环庚酮和吖啶的衍生物及其用途
CN108314663A (zh) * 2007-05-10 2018-07-24 多格伍德药品公司 芴、蒽、呫吨、二苯并环庚酮和吖啶的衍生物及其用途
CN108314663B (zh) * 2007-05-10 2022-05-13 多格伍德药品公司 芴、蒽、呫吨、二苯并环庚酮和吖啶的衍生物及其用途
WO2016116527A1 (de) * 2015-01-20 2016-07-28 Cynora Gmbh Organische moleküle, insbesondere zur verwendung in optoelektronischen bauelementen

Also Published As

Publication number Publication date
JPS57118540A (en) 1982-07-23
ZA818107B (en) 1982-10-27
KR830007489A (ko) 1983-10-21

Similar Documents

Publication Publication Date Title
EP0005231A2 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
AT368131B (de) Verfahren zur herstellung von neuen 9-aminoalkyl- fluorenen und von deren salzen
CH641757A5 (en) O-Alkylated hydroxylamines and process for the preparation thereof
EP0019172A1 (de) 6-Substituierte 11-Alkylen-morphantridine, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel
EP0122488B1 (de) Bis-(Piperazinyl- bzw. Homopiperazinyl)-Alkane
DE3044072A1 (de) Bis-aminomehtyl-anthrachinon-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
EP0052853A1 (de) Bis-Aminomethyl-anthrachinon-Derivate, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung
CH635834A5 (de) Dibenzo(d,g)(1,3,6)dioxazocin-derivate, verfahren zu ihrer herstellung und die diese verbindungen enthaltenden arzneimittelpraeparate.
DE2121996C3 (de) Dibasische Äther des 2,6- und 2,7-Dihydroxyanthrachinons der Herstellung und pharmazeutische Zubereitung
DE2631080A1 (de) 4-(3-substituierte-amino-2-hydroxy) propoxy-2-alkyl-isocarbostyril-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
CH634545A5 (en) 1-Phenyl-1-methoxy-2-aminoethane derivatives, and a process for their preparation
DE3117984A1 (de) Bis-(aminomethyl)-anthrachinon-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
AT398569B (de) Verfahren zur herstellung neuer tricyclischer kondensierter dibenzoderivate
EP0427161B1 (de) Picolylselenobenzamide von Aminopyridinen, Anilinen und Picolylaminen
EP0137993B1 (de) Neue 11-Piperazinyl-5H-imidazo[2,1-c][1,4]benzodiazepine, Verfahren zu ihrer Herstellung und Zwischenprodukte und erstere enthaltende Arzneimittel
DE2923817B1 (de) (3-Alkylamino-2-hydroxypropoxy)-furan-2-carbonsaeureanilide und deren physiologisch vertraegliche Saeureadditionssalze und Verfahren zu deren Herstellung sowie Arzneimittel mit einem Gehalt dieser Verbindungen
EP0004904B1 (de) 2-Amino-3a,4,5,6-tetrahydro-perimidin-Derivate, diese enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
AT324342B (de) Verfahren zur herstellung von neuen 6-aza-3h-1,4-benzodiazepinen und ihren salzen
DE2108185A1 (en) N-(3-aminoalkyl-2-oxo-2h-1-benzopyran-7-yl) ureas - as coronary vasodilators
DE2537878A1 (de) Substituierte 2,6-diamino-anthrachinone und verfahren zu ihrer herstellung
AT361473B (de) Verfahren zur herstellung von neuen thiazoli- dinderivaten und von deren saeureadditionssalzen
DD235870A5 (de) Verfahren zur herstellung von 3-substituierten thiopyronen
DE2428640A1 (de) Anthelmintische verbindungen und verfahren zu ihrer herstellung
AT265281B (de) Verfahren zur Herstellung von neuen Azepinderivaten sowie von ihren Additionssalzen mit anorganischen oder organischen Säuren
DE1695695C3 (de) Verfahren zur Herstellung von 2-Aminofuro eckige Klammer auf 2,3-d eckige Klammer zu thiazolen

Legal Events

Date Code Title Description
AG Has addition no.

Ref country code: DE

Ref document number: 3117984

Format of ref document f/p: P

AG Has addition no.

Ref country code: DE

Ref document number: 3117984

Format of ref document f/p: P

8130 Withdrawal